Digital pathology startup Proscia announces $23M Series B and plans for growth

By Author Proscia | December 1, 2020

Six-year-old digital pathology startup Proscia  sees some plans for growth after announcing it raised a Series B Tuesday.

The $23 million round was led by Scale Venture Partners with participation from Hitachi Ventures and brings the startup’s total fundraising up to $35 million, after closing a Series A in 2018 and a seed round in 2016.

The company said it plans to use the funds to meet a growing demand for digital pathology across research and diagnostics, including in cancer research. Its signature product, the Concentriq software platform, integrates with the technologies of anatomic pathology labs and offers a launching point for AI applications within a lab.

Our website uses cookies. By using this site, you agree to its use of cookies.